Vol. 38 Iss. 11 - January 17, 2022

| | Table of Contents »
Chapter 219

Notice is hereby given in accordance with § 2.2-4007.01 of the Code of Virginia that the State Board of Health intends to consider promulgating 12VAC5-219, Prescription Drug Price Transparency Regulation. The purpose of the proposed action is to add a new regulation establishing the requirements to report prescription drug price information. The new regulation is necessary to meet the statutory mandate of Chapter 304 of the 2021 Acts of Assembly, Special Session I, which requires the specification of prescription drugs for the purpose of data collection and procedures for auditing information provided by health carriers, pharmacy benefits managers, wholesale distributors, and manufacturers, as well as a schedule of civil penalties for failure to report the information required based on the severity of the violation.

The agency does not intend to hold a public hearing on the proposed action after publication in the Virginia Register.

Statutory Authority: §§ 32.1-12 and 32.1-23.4 of the Code of Virginia.

Public Comment Deadline: February 16, 2022.

Agency Contact: Michael Sarkissian, Director, Data and Quality, Office of Information Management, Virginia Department of Health, 9960 Mayland Drive, Suite 401, Richmond, VA 23233, telephone (804) 229-0517, FAX (804) 527-4502, or email

VA.R. Doc. No. R22-6828; Filed December 22, 2021
| | Table of Contents »